AEGiS-SC: AIDS Experts Map Out Battle Plans; Specialists gather in S.F., outline prevention needs San Francisco ChronicleImportant note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
Click here to return to San Francisco Chronicle main menu
DonateNow


AIDS Experts Map Out Battle Plans; Specialists gather in S.F., outline prevention needs

San Francisco Chronicle; Tuesday, April 21, 1998
David Perlman, Chronicle Science Editor


AIDS specialists from 38 countries joined yesterday to set their highest priorities for prevention strategies to save entire generations from a disease now ravaging the developing world more powerfully than ever before.

In virtually every country outside the industrialized West, the experts agreed, the most desperate needs are abundantly clear.

-- Nationwide centers for confidential counseling and testing for HIV, the AIDS virus, are lacking everywhere.

-- Supplies of the AIDS drug AZT, now proven to prevent transmission of HIV from most infected pregnant women to their unborn infants, are unaffordable in virtually every poor nation.

-- Kits to test national blood supplies before transfusions are virtually unobtainable within the meager health budgets of most of the nations.

--Condoms, the best physical barrier against the virus, must be marketed far more aggressively, although ample supplies are too often unavailable.

Yet all these needs, the prevention experts agreed, cost money -- and the developed world's financial help is sorely lacking. Increased taxes on wealthy individuals and multinational corporations may be needed, the experts said.

The 200 prevention experts had gathered in San Francisco over the weekend for a specialized workshop seeking practical measures for combatting the epidemic. Hosts were the AIDS Research Institute of the University of California in San Francisco and the Fogarty International Center of the National Institutes of Health in Bethesday, Md.

The meeting's background was ominous indeed: The latest United Nations figures show that more than 30 million people are now living with HIV infections or with AIDS itself -- 90 percent of them in the developing world

--and nearly 12 million have died since the global epidemic emerged in the late 1970s.

In the epidemic's newest surge, women account for more than 40 per cent of the victims, and already 8.2 million children have been orphaned by the disease, the UN figures show.

To Thomas J. Coates, director of UCSF's AIDS Research Center, the major goal for the world must lie in prevention -- "to save the next generation and the generation after that," as he put it. It is useless, he said, to think of an affordable, effective AIDS vaccine for at least two generations, and drug treatments, no matter how effective, are far beyond the capacity of most poor nations.

Elizabeth Ngugi, an AIDS specialist at the University of Nairobi in Kenya, voiced the concern typical of all the experts when she said: "We don't have voluntary testing centers in my country, we don't have AZT, we don't have drugs for treating other sexually transmitted diseases that open the way for AIDS infections, so how can we protect the next generation when our women cannot protect themselves?

"Where is the partnership between our developing countries and the superpowers? It doesn't exist."

And from Martha Bulter deLister of the Dominican Republic, came this complaint: "President Clinton has been in South America to lead the nations toward a new free market, but health was not even on the agenda, AIDS was not on the agenda."

The international experts noted that test kits for screening blood supplies cost only 50 cents each, while administering AZT to an HIV-positive pregnant woman costs only $50. That is cheap prevention, they agreed -- and certainly far cheaper than the $37,000 a year it costs to run a clinical trial on a new triple-combination drug treatment in a developing nation where prevention is so far more important to saving future lives.


980421
SC980420


Copyright © 1998 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com.   http://www.sfgate.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .